OTCMKTS:APPB Applied Biosciences (APPB) Stock Price, News & Analysis → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free APPB Stock Alerts $0.0002 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.00▼$0.10VolumeN/AAverage Volume3,764 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Applied Biosciences alerts: Email Address Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> About Applied Biosciences Stock (OTCMKTS:APPB)Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.Read More APPB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APPB Stock News HeadlinesMay 11, 2023 | msn.comApplied DNA Sciences GAAP EPS of $0.05 beats by $0.25, revenue of $4.41M beats by $0.28MMarch 27, 2023 | forbes.comMeet The Three Berkeley Dropouts Empowering Biotechs With Code-Free Cloud-Based BiocomputingApril 25, 2024 | Behind the Markets (Ad)Will this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!January 10, 2023 | msn.comHarvard’s ‘RoboBee’ project lifts off as a surgical-tech companyJanuary 5, 2023 | finance.yahoo.comTargeted Bioscience Launches Innovative Solutions for Biotech IndustryNovember 1, 2022 | seekingalpha.comAptose Biosciences Inc. (APTO) Q3 2022 Earnings Call TranscriptOctober 4, 2022 | markets.businessinsider.comAlafair Biosciences Announces VersaWrap® Sales MilestoneSeptember 19, 2022 | thestreet.comInvitrogen, Applied Biosystems Ink MergerApril 25, 2024 | Behind the Markets (Ad)Will this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!September 12, 2022 | finance.yahoo.comAldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness PortfolioAugust 9, 2022 | apnews.comThermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping KitJune 23, 2022 | apnews.comBioAxone BioSciences Announces Patent Issued for Pharmaceutical Compositions of BA-210, a Rho Inhibitor for the Treatment of Spinal Cord InjuryJune 10, 2022 | benzinga.comApplied Biosciences (OTC:APPB), Analyst Ratings, Price Targets, PredictionsMay 12, 2022 | finance.yahoo.comWILLOW BIOSCIENCES REPORTS FIRST QUARTER 2022 RESULTSMarch 18, 2022 | benzinga.comNon-Profit Supporting Veterans Gets $3M To Explore Psychedelic Drugs As Treatment For Mental Health IssuesMarch 5, 2022 | benzinga.comNeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry TreatmentsFebruary 26, 2022 | benzinga.comGreenway Greenhouse Reports Second Consecutive Quarter Of Positive Adjusted EBITDA, Continues To Drive Towards ProfitabilityJanuary 21, 2022 | benzinga.comNew York Will Generate Over $1B In Marijuana Taxes, Government Officials PredictJanuary 12, 2022 | benzinga.comWhy Tilray Shares Must Clear This Key Level For Immediate Reversal Following Q2 Earnings PrintJanuary 11, 2022 | benzinga.comBitcoin Will Outpace Stocks In 2022 Amid Fed Rate Hikes: ReportJanuary 2, 2022 | benzinga.comOhio Woman Gets Surprise Air Mail When Drone Carrying Cannabis Crashes Into HomeDecember 30, 2021 | benzinga.comEx-NFL Star Marvin Washington Calls Psilocybin The 'Next Big Moon Shot' For Athletes And SocietyDecember 26, 2021 | benzinga.comForgotten Psychedelics: What Is 2C-B?December 18, 2021 | benzinga.comThis Anti-Racism Guide For Cannabis Businesses Is A Must-Read For Leaders And EntrepreneursNovember 23, 2021 | benzinga.comWhat Is HHC And Does It Get You High?November 15, 2021 | benzinga.com7 Brilliant Artists Who Integrate Cannabis-Based Themes In Their WorkNovember 3, 2021 | benzinga.comSproutly Canada Reports Unaudited Q2 Results With Lower Revenue YoY, Improved Net LossSee More Headlines Receive APPB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:APPB CUSIPN/A CIK1607549 Webwww.appliedbiocorp.com Phone(212) 401-0097FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Christopher Michael Bridges (Age 45)President Mr. David Fiene (Age 53)Controller Key Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors APPB Stock Analysis - Frequently Asked Questions How have APPB shares performed in 2024? Applied Biosciences' stock was trading at $0.0002 on January 1st, 2024. Since then, APPB shares have increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. What other stocks do shareholders of Applied Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Biosciences investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES), Archer-Daniels-Midland (ADM), AGNC Investment (AGNC) and AMC Entertainment (AMC). How do I buy shares of Applied Biosciences? Shares of APPB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:APPB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyI’m afraid WWIII is a very real possibility Porter & CompanyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Biosciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
